References
- CampbellJDAlexandrovAKimJDistinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomasNat Genet201648660761627158780
- SunSSchillerJHGazdarAFLung cancer in never smokers–a different diseaseNat Rev Cancer2007777879017882278
- SametJMAvila-TangEBoffettaPLung cancer in never smokers: clinical epidemiology and environmental risk factorsClin Cancer Res200915185626564519755391
- CardarellaSJohnsonBEThe impact of genomic changes on treatment of lung cancerAm J Respir Crit Care Med2013188777077523841470
- VaishnaviACapellettiMLeATOncogenic and drug-sensitive NTRK1 rearrangements in lung cancerNat Med201319111469147224162815
- CiardielloFTortoraGA novel approach in the treatment of cancer: targeting the epidermal growth factor receptorClin Cancer Res20017102958297011595683
- LynchTJBellDWSordellaRActivating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinibN Engl J Med2004350212129213915118073
- PaezJGJannePALeeJCEGFR mutations in lung cancer: correlation with clinical response to gefitinib therapyScience200430456761497150015118125
- LomazziMMoroniMCJensenMRFrittoliEHelinKSuppression of the p53- or pRB-mediated G1 checkpoint is required for E2F-induced S-phase entryNat Genet200231219019411992123
- OzennePEyminBBrambillaEGazzeriSThe ARF tumor suppressor: structure, functions and status in cancerInt J Cancer2010127102239224720549699
- TimofeevaMNHungRJRafnarTTransdisciplinary Research in Cancer of the Lung (TRICL) Research TeamInfluence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controlsHum Mol Genet201221224980499522899653
- YangXYangLDaiWYeBRole of p14ARF and p15INK4B promoter methylation in patients with lung cancer: a systematic meta-analysisOnco Targets Ther201696977698527956841
- LiZDingSZhongQLiGZhangYHuangXCSignificance of MMP11 and P14(ARF) expressions in clinical outcomes of patients with laryngeal cancerInt J Clin Exp Med201589155811559026629052
- CabralVDCerskiMRSaBIKliemannLMp14 expression differences in ovarian benign, borderline and malignant epithelial tumorsJ Ovarian Res2016916927770808
- PareRShinJSLeeCSIncreased expression of senescence markers p14(ARF) and p16(INK4a) in breast cancer is associated with an increased risk of disease recurrence and poor survival outcomeHistopathology201669347949126843058
- ItoTNishidaNFukudaYNishimuraTKomedaTNakaoKAlteration of the p14(ARF) gene and p53 status in human hepatocellular carcinomasJ Gastroenterol200439435536115168247
- ZhenYChunleiGWenzhiSClinicopathologic significance of legumain overexpression in cancer: a systematic review and meta-analysisSci Rep201551659926607955
- HigginsJPThompsonSGDeeksJJAltmanDGMeasuring inconsistency in meta-analysesBMJ2003327741455756012958120
- DerSimonianRLairdNMeta-analysis in clinical trialsControl Clin Trials1986731771883802833
- MantelNHaenszelWStatistical aspects of the analysis of data from retrospective studies of diseaseJ Natl Cancer Inst195922471974813655060
- SongFGilbodySBias in meta-analysis detected by a simple, graphical test. Increase in studies of publication bias coincided with increasing use of meta-analysisBMJ19983167129471
- PetersJLSuttonAJJonesDRAbramsKRRushtonLComparison of two methods to detect publication bias in meta-analysisJAMA2006295667668016467236
- ChenDPangJWWangWXiaoLZuGFClinicopathological significance and expression of E2F-1, c-myc and p14ARF protein in squamous cell carcinoma and adenocarcinoma of lungChin J Cancer Prev Treat201219115118
- YangZHYongHRJinKWGaoQZhangLThe expression of p14arf in lung cancerChinese Journal of Ethnomedicine & Ethnopharmacy20080746
- YangTDWuJFLiXJFanWYWangYLRelationship between the expression of p14ARF, mtp53 protein and clinical pathological parameters in non-small cell lung cancerJ Xinxiang Med Coll200825336339
- ZhaoZHWangSFCongDGYuLWangJCorrelation of the expression of pokemon with p14ARF and bcl-2 and their effects on prognosis of non small cell lung cancerTumor200828121124
- MascauxCBexFMartinBThe role of NPM, p14arf and MDM2 in precursors of bronchial squamous cell carcinomaEur Respir J200832367868618480108
- TianKHLinLSJiaYTGuoXJZhangLPromoter methylation status and protein expression of p14ARF gene in squamous cell carcinoma and adenocarcinoma of the lungChin J Lung Cancer2006914044
- TianKHShenYLuoYRZhangLExpression of p14ARF gene in non-small cell lung cancerMed J Qilu200520389393
- TianKHZhaoHRZhaoFZhangLQuHCExpression of p14ARF, p16INK4a, and p53 gene in non-small cell lung cancerChin J Clin Oncol200431376383
- HuYDLiJGYeFMStudy on the expressions and clinical significances of cell cycle control protein p14ARF in non-small cell lung cancerSichuan Med J20042511911193
- ChaussadeLEyminBBrambillaEGazzeriSExpression of p15 and p15.5 products in neuroendocrine lung tumours: relationship with p15(INK4b) methylation statusOncogene200120456587659611641784
- CortotABYounesMMartel-PlancheGMutation of TP53 and alteration of p14(arf) expression in EGFR- and KRAS-mutated lung adenocarcinomasClin Lung Cancer201415212413024169260
- LiJGHuYDYeMFThe co-expression and clinical significance of p14ARF and p16INK4a proteins in non-small cell lung cancerChin J Clin Oncol20053210211024
- LiJGYeFMHuYDExpressions of p14ARF and p16INK4a proteins in small cell lung cancer and the clinical significanceActa Acad Med Militaris Tertia20042610981101
- ChenQKDingJAGaoWImmunohistochemical analysis of P14ARF protein expression in non-small cell lung cancer: its prognostic signifi-canceChin J Lung Cancer200364283285
- XueQSanoTKashiwabaraKSaitoMOyamaTNakajimaTAberrant expression of pRb, p16, p14ARF, MDM2, p21 and p53 in stage I adenocarcinomas of the lungPathol Int200252210310911940214
- MuerAOverkampTGillissenBp14(ARF)-induced apoptosis in p53 protein-deficient cells is mediated by BH3-only protein-independent derepression of Bak protein through down-regulation of Mcl-1 and Bcl-xL proteinsJ Biol Chem201228721173431735222354970
- ZindyFEischenCMRandleDHMyc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalizationGenes Dev19981215242424339694806
- WilliamsRTRousselMFSherrCJArf gene loss enhances oncogenicity and limits imatinib response in mouse models of Bcr-Abl-induced acute lymphoblastic leukemiaProc Natl Acad Sci U S A2006103176688669316618932
- HarrisSLLevineAJThe p53 pathway: positive and negative feedback loopsOncogene200524172899290815838523
- JinLXuLSongXWeiQSturgisEMLiGGenetic variation in MDM2 and p14ARF and susceptibility to salivary gland carcinomaPLoS One2012711e4936123145162
- MomandJZambettiGPOlsonDCGeorgeDLevineAJThe mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell1992697123712451535557
- JohanssonHJEl-AndaloussiSHolmTCharacterization of a novel cytotoxic cell-penetrating peptide derived from p14ARF proteinMol Ther2008161115123
- EyminBKarayanLSeitePHuman ARF binds E2F1 and inhibits its transcriptional activityOncogene20012091033104111314038
- MartelliFHamiltonTSilverp19ARF targets certain E2F species for degradationProc Natl Acad Sci U S A20019884455446011274364